|1.||Mitra, S K: 3 articles (01/2003 - 09/2000)|
|2.||Anturlikar, S D: 2 articles (09/2001 - 09/2000)|
|3.||Venkataranganna, M V: 2 articles (09/2001 - 09/2000)|
|4.||Gopumadhavan, S: 2 articles (09/2001 - 09/2000)|
|5.||Sarma, D N K: 1 article (01/2003)|
|6.||Gupta, Monika: 1 article (01/2003)|
|7.||Yeh, S F: 1 article (01/2003)|
|8.||Seshadri, S J: 1 article (09/2001)|
|9.||Venkatesha Udupa, U: 1 article (09/2001)|
|10.||Sheshadri, S J: 1 article (09/2000)|
|1.||Hepatocellular Carcinoma (Hepatoma)
01/01/2003 - "In the present study, we examined the activity of HD-03, a polyherbal formulation, on two hepatitis B surface antigen (HBsAg) expressing human hepatocellular carcinoma cell lines, PLC/PRF/5 and HepG2/A2. "
01/01/2003 - "Downregulation of hepatitis B surface antigen expression in human hepatocellular carcinoma cell lines by HD-03, a polyherbal formulation."
04/01/1999 - "In the present study HD-03, a herbal formulation was investigated for its anti-cholestatic activity in TAA-induced cholestasis in anaesthetized guinea pigs. "
04/01/1999 - "Anti-cholestatic activity of HD-03, a herbal formulation in thioacetamide (TAA)-induced experimental cholestasis."
09/01/2000 - "Inhibition of experimental cirrhosis in rats by HD-03."
09/01/2000 - "The responses such as membrane stabilization, hepatocellular regeneration, and inhibition of collagen formation are the contributing factors in the correction of TAA-induced cirrhosis by HD-03."
09/01/2000 - "To investigate the protective effect of HD-03 in experimental cirrhosis following chronic intoxication with thioacetamide (TAA). "
|1.||Hepatitis B Surface Antigens (HBsAg)